The mean relapse rate for the HIV-positive IBD group was 0.016/year of follow-up as compared with 0.053/year of follow-up in the matched controls (p < 0.05) with no relapses reported with a CD4 T-lymphocyte count of < 500 [2]. Here, CD4 is linked to inflammatory bowel disease.